Donna M. Nichols
Keine laufenden Positionen mehr
Profil
Donna M.
Nichols worked as a Director of Financial Reporting at Adolor Corp.
from 1996 to 2003.
She then worked as an Accounting Director at Auxilium Pharmaceuticals LLC from 2004 to 2009.
From 2009 to 2017, she worked at Societal CDMO, Inc. as a Chief Accounting Officer, VP & Controller.
Ms. Nichols received an undergraduate degree from Rider University.
Ehemalige bekannte Positionen von Donna M. Nichols
| Unternehmen | Position | Ende |
|---|---|---|
| SOCIETAL CDMO, INC. | Finanzdirektor/CFO | 05.07.2016 |
| AUXILIUM PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | - |
Adolor Corp.
 Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | Corporate Officer/Principal | 01.06.2003 |
Ausbildung von Donna M. Nichols
| Rider University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SOCIETAL CDMO, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Auxilium Pharmaceuticals LLC
 Auxilium Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Auxilium Pharmaceuticals LLC develops and markets pharmaceutical products. It specializes in men's healthcare area and has product portfolio and pipeline in orthopedics, dermatology and other therapeutic areas. The firm products include edex, Osbon, ErecAid, STENDRA, TESTOPEL, XIAFLEX and Testim. The company was founded by Gerri A. Henwood and Jane Holmes Hollingsworth in 1999 and is headquartered in Chesterbrook, PA. | Health Technology |
Adolor Corp.
Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | Health Technology |
